Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis.

@article{Eckman2003CanPB,
  title={Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis.},
  author={Mark H. Eckman and Jonathan Rosand and Katherine A. Knudsen and Daniel Elliot Singer and Steven A. Greenberg},
  journal={Stroke},
  year={2003},
  volume={34 7},
  pages={
          1710-6
        }
}
BACKGROUND AND PURPOSE Warfarin increases both the likelihood and the mortality of intracerebral hemorrhage (ICH), particularly in patients with a history of prior ICH. In light of this consideration, should a patient with both a history of ICH and a clear indication for anticoagulation such as nonvalvular atrial fibrillation be anticoagulated? In the absence of data from a clinical trial, we used a decision-analysis model to compare the expected values of 2 treatment strategies-warfarin and no… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 141 CITATIONS, ESTIMATED 48% COVERAGE

Antithrombotic medicines following intracerebral haemorrhage: where's the evidence?

  • Therapeutic advances in drug safety
  • 2011
VIEW 4 EXCERPTS
CITES BACKGROUND, METHODS & RESULTS
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2004
2019

CITATION STATISTICS

  • 7 Highly Influenced Citations

  • Averaged 8 Citations per year from 2017 through 2019

References

Publications referenced by this paper.
SHOWING 1-10 OF 40 REFERENCES

Similar Papers

Loading similar papers…